Evidence map›Paper›PMID 34856874›Full record

ArticleHuman vaccines & immunotherapeutics2021

Effect of Hurricane Maria on HPV, Tdap, and meningococcal conjugate vaccination rates in Puerto Rico, 2015-2019.

Vivian Colón-López, Olga L Díaz-Miranda, Diana T Medina-Laabes, Roxana Soto-Abreu, Idamaris Vega-Jimenez, Ana P Ortiz, Erick L Suárez

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vivian Colón-LópezPuerto Rico Cancer Control and Population Sciences Division, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico.ORCID 0000-0002-0008-1539
Olga L Díaz-MirandaPuerto Rico Cancer Control and Population Sciences Division, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico.
Diana T Medina-LaabesPuerto Rico Cancer Control and Population Sciences Division, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico.
Roxana Soto-AbreuPuerto Rico Cancer Control and Population Sciences Division, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico.
Idamaris Vega-JimenezPuerto Rico Cancer Control and Population Sciences Division, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico.
Ana P OrtizPuerto Rico Cancer Control and Population Sciences Division, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico.
Erick L SuárezDepartment of Biostatistics and Epidemiology, Graduate School of Public Health, University of Puerto Rico Medical Science Campus, San Juan, Puerto Rico.

Funding

Implementation of School-Entry Policies for Human Papillomavirus VaccinationR01CA232743 · NCI · COMPREHENSIVE CANCER CENTER/ UNIV/PR · PI COLON, VIVIAN · 2019 to 2023
$1.9M
NCI NIH HHS R01 CA232743
6 · The paper itself

Abstract

In September 2017, Hurricane Maria devastated the Caribbean region, among them the US territory of Puerto Rico (PR). Vaccination distribution and uptake suffered from the impact. This study evaluated the trends in monthly vaccination initiation rates for human papilloma virus (HPV), Tdap and meningococcal conjugate (MenACWY) adolescent vaccines from 2015 to 2019, during which it was possible to observe and analyze the impact of Hurricane Maria on vaccine initiation. Monthly initiation rates were estimated. Age-standardized initiation rate ratio (SRR) and 95% CI were estimated. The analysis included 85,340 adolescents; 52.3% were male, and 47.7% were females. September 2017 showed HPV vaccine initiation had the lower rates of all the studied vaccines, with a rate of 75% after the disaster (from a rate of almost 90% in July 2017). Tdap and MenACWY vaccines rates remained above 90% in the same period. The SRR of HPV vaccine for September and October 2017 showed an estimated reduction of 5% and 8% in vaccine initiation rates, respectively for each month, when 2016 was the reference year (

Indexed as

AlphapapillomavirusCyclonic StormsDiphtheria-Tetanus-acellular Pertussis VaccinesMeningococcal VaccinesPapillomavirus InfectionsPapillomavirus VaccinesAdolescentFemaleHumansImmunization ScheduleMalePapillomaviridaePuerto RicoVaccinationDiphtheria-Tetanus-acellular Pertussis VaccinesMeningococcal VaccinesPapillomavirus VaccinesHPV vaccineHurricane Mariaimmunizationmeningococcal vaccinenatural disastersTdap vaccine

Identifiers

PMID34856874
PMCPMC8903914

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.